{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:54:29Z","timestamp":1791312869767,"version":"4.3.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1997,3,1]],"date-time":"1997-03-01T00:00:00Z","timestamp":857174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1997,3,1]],"date-time":"1997-03-01T00:00:00Z","timestamp":857174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology and Immunopathology"],"published-print":{"date-parts":[[1997,3]]},"DOI":"10.1006\/clin.1996.4311","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T11:45:11Z","timestamp":1032176711000},"page":"203-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Aberrant Immunity in the Central Nervous System in Relation to Disease Progression in HAM\/TSP"],"prefix":"10.1006","volume":"82","author":[{"given":"Makoto","family":"Matsui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/clin.1996.4311_II964311C1","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity","volume":"1","author":"Osame","year":"1986","journal-title":"Lancet"},{"key":"10.1006\/clin.1996.4311_II964311C2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","article-title":"Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis","volume":"2","author":"Gessain","year":"1985","journal-title":"Lancet"},{"key":"10.1006\/clin.1996.4311_II964311C3","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199304223281608","article-title":"Pathogenesis of diseases induced by human lymphotropic virus type I infection","volume":"328","author":"H\u00f6llsberg","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clin.1996.4311_II964311C4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0022-510X(94)00266-Q","article-title":"Progression of neurological disability in HTLV-I-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP)","volume":"129","author":"Ara\u00fajo","year":"1995","journal-title":"J. Neurol. Sci."},{"key":"10.1006\/clin.1996.4311_II964311C5","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0022-510X(95)00142-O","article-title":"A follow-up study on spastic paraparesis in Japanese HAM\/TSP","volume":"132","author":"Kuroda","year":"1995","journal-title":"J. Neurol. Sci."},{"key":"10.1006\/clin.1996.4311_II964311C6","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/ana.410240220","article-title":"Activated T-lymphocytes with polyclonal gammopathy in patients with human T-lymphotropic virus type I-associated myelopathy","volume":"24","author":"Mori","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1006\/clin.1996.4311_II964311C7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0022-510X(91)90119-R","article-title":"Analysis of factors of relevance to rapid clinical progression in HTLV-I-associated myelopathy","volume":"105","author":"Kuroda","year":"1991","journal-title":"J. Neurol. Sci."},{"key":"10.1006\/clin.1996.4311_II964311C8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0022-510X(95)00036-2","article-title":"Characterization of humoral and cellular immunity in the central nervous system of HAM\/TSP","volume":"130","author":"Matsui","year":"1995","journal-title":"J. Neurol. Sci."},{"key":"10.1006\/clin.1996.4311_II964311C9","series-title":"Advances in CSF Protein Research and Diagnosis","article-title":"Cerebrospinal fluid profile indicative of clinical definite multiple sclerosis: A proposal, facts, issues, opportunities and perspective","author":"Tourtellotte","year":"1987"},{"key":"10.1006\/clin.1996.4311_II964311C10","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1084\/jem.158.6.1895","article-title":"Transient expression of interleukin 2 receptors. Consequences for T cell growth","volume":"158","author":"Cantrell","year":"1983","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1996.4311_II964311C11","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.4049\/jimmunol.133.3.1250","article-title":"Ta1","volume":"133","author":"Fox","year":"1984","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1996.4311_II964311C12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0165-2478(87)90001-0","article-title":"Minireview. Human T cell subsets","volume":"14","author":"Beverley","year":"1987","journal-title":"Immunol. Lett."},{"key":"10.1006\/clin.1996.4311_II964311C13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/330479a0","article-title":"A novel epitope of the LFA-1 antigen which can distinguish killer effector and suppressor cells in human CD8 cells","volume":"330","author":"Morimoto","year":"1987","journal-title":"Nature"},{"key":"10.1006\/clin.1996.4311_II964311C14","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/intimm\/1.4.450","article-title":"Evidence for differential expression of CD45 isoforms by precursors for memory-dependent and independent cytotoxic responses: Human CD8 memory CTLp selectively express CD45RO (UCHL1)","volume":"1","author":"Merkenschlager","year":"1989","journal-title":"Int. Immunol."},{"key":"10.1006\/clin.1996.4311_II964311C15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0022-510X(90)90060-Z","article-title":"Pathology of chronic myelopathy associated with HTLV-I infection (HAM\/TSP)","volume":"96","author":"Iwasaki","year":"1990","journal-title":"J. Neurol. Sci."},{"key":"10.1006\/clin.1996.4311_II964311C16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-3083.1990.tb02789.x","article-title":"CD26 antigen is a surface dipeptidyl peptidase IV (DPPIV) as characterized by monoclonal antibodies clone TII-19-4-7 and 4EL1C7","volume":"31","author":"Ulmer","year":"1990","journal-title":"Scand. J. Immunol."},{"key":"10.1006\/clin.1996.4311_II964311C17","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4049\/jimmunol.137.2.414","article-title":"Antigen reactive memory T cells are defined by Ta1","volume":"137","author":"Hafler","year":"1986","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1996.4311_II964311C18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1006\/cimm.1993.1145","article-title":"Increased protein kinase C activity in human memory T cells","volume":"149","author":"H\u00f6llsberg","year":"1993","journal-title":"Cell. Immunol."},{"key":"10.1006\/clin.1996.4311_II964311C19","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM198505303122201","article-title":"In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis","volume":"312","author":"Hafler","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clin.1996.4311_II964311C20","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ana.410290214","article-title":"Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: A quantitative polymerase chain reaction study","volume":"29","author":"Kira","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1006\/clin.1996.4311_II964311C21","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1128\/jvi.64.11.5682-5687.1990","article-title":"In vivo cellular tropism of human T-cell leukemia virus type 1","volume":"64","author":"Richardson","year":"1990","journal-title":"J. Virol."},{"key":"10.1006\/clin.1996.4311_II964311C22","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1212\/WNL.44.12.2295","article-title":"In situ demonstration of the HTLV-I genome in the spinal cord of a patient with HTLV-I-associated myelopathy","volume":"44","author":"Kuroda","year":"1994","journal-title":"Neurology"},{"key":"10.1006\/clin.1996.4311_II964311C23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ana.410370206","article-title":"Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy\/tropical spastic paraparesis patients by in situ hybridization","volume":"37","author":"Lehky","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1006\/clin.1996.4311_II964311C24","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/ana.410260405","article-title":"Tropical spastic paraparesis: a model of virus-induced, cytotoxic T-cell-mediated demyelination?","volume":"26","author":"Moore","year":"1989","journal-title":"Ann. Neurol."},{"key":"10.1006\/clin.1996.4311_II964311C25","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/00005072-199411000-00009","article-title":"Apoptosis of T lymphocytes in the spinal cord lesions in HTLV-I-associated myelopathy: A possible mechanism to control viral infection in the central nervous system","volume":"53","author":"Umehara","year":"1994","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1006\/clin.1996.4311_II964311C26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/ana.410320508","article-title":"HTLV-I-specific cytotoxic T lymphocytes in the cerebrospinal fluid of patients with HTLV-I-associated neurological disease","volume":"32","author":"Jacobson","year":"1992","journal-title":"Ann. Neurol."}],"container-title":["Clinical Immunology and Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090122996943111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090122996943111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:11:42Z","timestamp":1758762702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090122996943111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1997,3]]}},"alternative-id":["S0090122996943111"],"URL":"https:\/\/doi.org\/10.1006\/clin.1996.4311","relation":{},"ISSN":["0090-1229"],"issn-type":[{"value":"0090-1229","type":"print"}],"subject":[],"published":{"date-parts":[[1997,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aberrant Immunity in the Central Nervous System in Relation to Disease Progression in HAM\/TSP","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology and Immunopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/clin.1996.4311","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1997 Academic Press. All rights reserved.","name":"copyright","label":"Copyright"}]}}